Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate
Authors
Keywords
-
Journal
NATURE BIOTECHNOLOGY
Volume 34, Issue 11, Pages 1161-1167
Publisher
Springer Nature
Online
2016-10-11
DOI
10.1038/nbt.3697
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantification of cell viability and rapid screening anti-cancer drug utilizing nanomechanical fluctuation
- (2016) Shangquan Wu et al. BIOSENSORS & BIOELECTRONICS
- Characterizing Cellular Biophysical Responses to Stress by Relating Density, Deformability, and Size
- (2015) Sangwon Byun et al. BIOPHYSICAL JOURNAL
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
- (2015) M. Andreeff et al. CLINICAL CANCER RESEARCH
- Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
- (2015) M. Verreault et al. CLINICAL CANCER RESEARCH
- An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
- (2015) Oliver Jonas et al. Science Translational Medicine
- Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation
- (2014) Andrew A Lane et al. NATURE GENETICS
- Patient-derived models of acquired resistance can identify effective drug combinations for cancer
- (2014) Adam S. Crystal et al. SCIENCE
- EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
- (2014) J. M. Francis et al. Cancer Discovery
- Genomic impact of transient low-dose decitabine treatment on primary AML cells
- (2013) J. M. Klco et al. BLOOD
- Inconsistency in large pharmacogenomic studies
- (2013) Benjamin Haibe-Kains et al. NATURE
- What a Tangled Web We Weave: Emerging Resistance Mechanisms to Inhibition of the Phosphoinositide 3-Kinase Pathway
- (2013) S. J. Klempner et al. Cancer Discovery
- Direct observation of mammalian cell growth and size regulation
- (2012) Sungmin Son et al. NATURE METHODS
- Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
- (2012) Jorge E. Cortes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
- (2012) Levi A. Garraway et al. Cancer Discovery
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Evidence for label-retaining tumour-initiating cells in human glioblastoma
- (2011) Loic P. Deleyrolle et al. BRAIN
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays
- (2011) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour evolution inferred by single-cell sequencing
- (2011) Nicholas Navin et al. NATURE
- Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
- (2011) Justin D. Lathia et al. PLoS One
- Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3
- (2010) Thomas Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Using buoyant mass to measure the growth of single cells
- (2010) Michel Godin et al. NATURE METHODS
- Predicting drug susceptibility of non–small cell lung cancers based on genetic lesions
- (2009) Martin L. Sos et al. JOURNAL OF CLINICAL INVESTIGATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started